BioSig Technologies, Inc. (NASDAQ: BSGM) Executive Vice President Natasha Drapeau tells Proactive the Westport, Connecticut-based medical technology company has formed its fifth R&D program collaboration with the Mayo Foundation for Medical Education and Research. Drapeau explains how the program will aim to develop Artificial Intelligence and machine learning-powered software for its PURE EP system.
BioSig forms R&D program with Mayo Clinic to develop AI and machine learning for its PURE EP System
